DaVita Inc. (NYSE:DVA) Shares Bought by TD Asset Management Inc

TD Asset Management Inc lifted its holdings in shares of DaVita Inc. (NYSE:DVA - Free Report) by 8.5% in the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 187,433 shares of the company's stock after buying an additional 14,742 shares during the period. TD Asset Management Inc owned about 0.24% of DaVita worth $28,672,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently modified their holdings of the business. Norges Bank bought a new stake in shares of DaVita in the 4th quarter valued at about $7,297,000. Allstate Corp purchased a new stake in shares of DaVita during the fourth quarter valued at approximately $203,000. California Public Employees Retirement System increased its position in DaVita by 75.1% in the fourth quarter. California Public Employees Retirement System now owns 196,788 shares of the company's stock worth $29,430,000 after buying an additional 84,375 shares during the last quarter. Wellington Management Group LLP boosted its holdings in shares of DaVita by 9.1% in the fourth quarter. Wellington Management Group LLP now owns 2,711 shares of the company's stock worth $405,000 after acquiring an additional 227 shares during the period. Finally, Franklin Resources Inc. boosted its stake in DaVita by 2.9% during the fourth quarter. Franklin Resources Inc. now owns 56,517 shares of the company's stock valued at $8,452,000 after buying an additional 1,616 shares during the period. Institutional investors and hedge funds own 90.12% of the company's stock.

DaVita Trading Down 1.4%

Shares of NYSE:DVA traded down $1.93 during trading on Friday, hitting $138.44. The company had a trading volume of 686,266 shares, compared to its average volume of 850,764. The stock has a market cap of $10.45 billion, a price-to-earnings ratio of 13.72, a price-to-earnings-growth ratio of 1.00 and a beta of 1.11. DaVita Inc. has a one year low of $131.76 and a one year high of $179.60. The company has a fifty day simple moving average of $140.44 and a two-hundred day simple moving average of $148.08. The company has a debt-to-equity ratio of 23.18, a current ratio of 1.25 and a quick ratio of 1.20.

DaVita (NYSE:DVA - Get Free Report) last posted its quarterly earnings data on Monday, May 12th. The company reported $2.00 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.75 by $0.25. The business had revenue of $3.22 billion during the quarter, compared to analyst estimates of $3.22 billion. DaVita had a return on equity of 176.11% and a net margin of 6.63%. The company's revenue for the quarter was up 5.0% on a year-over-year basis. During the same period last year, the company earned $2.26 EPS. As a group, equities analysts forecast that DaVita Inc. will post 10.76 earnings per share for the current year.

Wall Street Analysts Forecast Growth

DVA has been the subject of several research analyst reports. Truist Financial dropped their price objective on DaVita from $170.00 to $164.00 and set a "hold" rating for the company in a research note on Monday, May 19th. Wall Street Zen raised DaVita from a "hold" rating to a "buy" rating in a research note on Friday, April 25th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and two have given a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus price target of $167.40.

Insider Activity

In other news, insider James O. Hearty sold 2,351 shares of the firm's stock in a transaction that occurred on Wednesday, July 23rd. The stock was sold at an average price of $150.00, for a total value of $352,650.00. Following the completion of the sale, the insider directly owned 26,038 shares of the company's stock, valued at $3,905,700. This trade represents a 8.28% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 2.00% of the stock is owned by insiders.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.